Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001437749-26-006421 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
10,833
Total Value
$70,469.75
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CMO & Head of Development | Class A Common Stock | โ | Mar 2, 2026 | Exercise/Conversion | 3,611 | $4.50 | $16,249.50 | 3,611 | Direct | โ | View Details | |
CMO & Head of Development | Class A Common Stock | โ | Mar 2, 2026 | Sale | 3,611 | $15.02 | $54,220.25 | 0 | Direct | โ | View Details | |
CMO & Head of Development | Stock Option (right to buy) | Derivative | Mar 2, 2026 | Exercise/Conversion | 3,611 | $0.00 | $0.00 | 249,167 | Direct | โ | View Details |